Close

BofA/Merrill Lynch Downgrades Adaptimmune Therapeutics plc (ADAP) to Underperform

Go back to BofA/Merrill Lynch Downgrades Adaptimmune Therapeutics plc (ADAP) to Underperform
(NASDAQ: ADAP) Delayed: 1.58 --0 (-0%)
Previous Close $1.58    52 Week High $12.85 
Open $1.58    52 Week Low $3.76 
Day High $1.58    P/E N/A 
Day Low $1.58    EPS $0.00 
Volume 50